Navigation Links
B. Braun Technology Wins Novation Specialty Infusion Pumps Contract Award

B. Braun Expands Contract Agreements to Include Specialty Pumps

BETHLEHEM, Pa., Nov. 5 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun) announced today it has signed a three-year agreement with Novation, the healthcare industry's leading contracting services company, to provide specialty infusion pumps to Novation's customers nationwide.

(Logo: )

Novation develops and manages contracts with more than 500 suppliers to the nearly 2,500 members of VHA Inc. and the University HealthSystem Consortium, two national healthcare alliances and nearly 12,000 members of Provista, LLC.

The agreement, which took effect Monday, is a multi-source award for ambulatory and syringe pumps.

"The Novation contract validates B. Braun's industry-leading technology," said Gale White, Vice President, Infusion Systems for B. Braun Medical Inc. "By adding this agreement, we're able to offer Novation customers advanced technology pumps that are easy to use, reduce medication errors and increase the safety of infusion therapy."

Ambulatory pumps covered under the agreement include the entire Curlin PainSmart(R) IOD Pain Management System, which B. Braun markets exclusively. The Curlin System is an advanced ambulatory electronic infusion system that offers a revolutionary safe, reliable and smart pain management technology for advanced pain therapy. Equipped with Information On Demand (IOD) technology for PCA, PCEA and epidural therapies, it is easy-to-use and flexible. A single pump can accommodate syringes, bags or bottles.

Novation customers now also have access to B. Braun syringe pumps. Designed with both adult and pediatric facilities in mind, the small, lightweight B. Braun SPACE System allows for flexibility and easy transport within a number of care settings.

At 9 inches by 6 inches and weighing only three pounds, the SPACE pumps can fit easily into a range of environments. The system is designed for higher acuity care facilities, offering a large drug library as well as the capability to build up to 24 pumps in a single bedside tower. Clinicians benefit from the compact size of the Perfusor(R) SPACE syringe pump in crowded operating room environments, where three pumps easily interlock on a pole clamp.

About Novation

Founded in 1998, Novation is the leading health care contracting services company for more than 2,500 members of VHA Inc. and the University HealthSystem Consortium (UHC), two national health care alliances and nearly 13,000 members of Provista, LLC. Novation offers its customers contract development and management, supply chain data and measurement, and industry knowledge and advocacy. Based in Irving, Texas, Novation develops and manages competitive contracts with more than 500 suppliers. VHA, UHC and Provista members used Novation contracts to purchase more than $33.1 billion in 2007. For more information on Novation, visit

About B. Braun

B. Braun is a global leader in infusion therapy and pain management and a pioneer in passive safety devices and PVC-/DEHP-free products. Every day, B. Braun employees worldwide share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance safety for patients, doctors and nurses.

Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services, B. Braun promotes best practices for continuous improvement of healthcare and, guided by its "Sharing Expertise" philosophy, helps today's healthcare workers address critical issues including environmental responsibility, medication errors reduction and infection prevention. For more information, call 800-227-2862, e-mail us at or visit B. Braun at

SOURCE B. Braun Medical Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Sinovac Named to Deloitte Technology Fast 50 China
2. ATS Forcefield Anti-platelet Technology Continues to Demonstrate Positive Results
3. Sundia MediTech Ranked #16 in Deloitte Technology Fast 50 China
4. eResearchTechnology Reports Third Quarter 2008 Results
5. Nonprofit Puts the Power to Cure Neurological Disease in the Hands of the Masses: Texting Technology Brings Awareness & Supports Research
6. InNexus Biotechnology Receives Patent Grants in Europe
7. Sigma-Aldrich Introduces Methylated DNA Quantification Technology for Epigenetic Research
8. InNexus Biotechnology CEO to Present at the 7th Annual BIO Investor Forum
9. BioWa Announces License of Biowas Potelligent(R) Technology to KaloBios Pharmaceuticals
10. Affitech Acquires Pharmexas Diabody Technology
11. Sigma-Aldrich Releases WTA2, a Transplex Whole Transcriptome Amplification Technology for Degraded RNA Samples
Post Your Comments:
(Date:11/27/2015)... November 27, 2015 ... popularity of companion diagnostics is one of ... market with pharmaceutical companies and diagnostic manufacturers ... tests. . --> ... report on global cancer biomarkers market spread ...
(Date:11/25/2015)... , Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: ... adopted a stockholder rights plan (Rights Plan) in an ... loss carryforwards (NOLs) under Section 382 of the Internal ... --> PharmAthene,s use of its NOLs could be ... as defined in Section 382 of the Code. In ...
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. ... Gorman , President and CEO of Neurocrine Biosciences, will ... Conference in New York . ... visit the website approximately 5 minutes prior to the ... replay of the presentation will be available on the ...
(Date:11/25/2015)... PORTLAND, Oregon , November 25, 2015 /PRNewswire/ ... Deep Market Research Report is a professional and ... Genomics industry.      (Logo: ... basic overview of the industry including definitions, classifications, ... analysis is provided for the international markets including ...
Breaking Biology Technology:
(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
(Date:10/29/2015)... , Oct. 29, 2015  Connected health pioneer, ... driving the explosion of technology-enabled health and wellness, and ... new book, The Internet of Healthy Things ... sensors or smartphones even existed, Dr. Kvedar, vice president, ... of health care delivery, moving care from the hospital ...
Breaking Biology News(10 mins):